ED Visit Rate 36.1 per 1,000 Older Adults With Alzheimer Disease
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
TUESDAY, Oct. 29, 2024 -- For adults aged 65 years and older with Alzheimer disease, the emergency department visit rate was 36.1 visits per 1,000 adults in 2020 to 2022, according to an October data brief published by the National Center for Health Statistics.
Loredana Santo, M.D., M.P.H., from the National Center for Health Statistics in Hyattsville, Maryland, and colleagues describe emergency department visits by adults aged 65 years and older with Alzheimer disease and compared them to visits by adults without Alzheimer disease using data from the National Hospital Ambulatory Medical Care Survey.
The researchers found that the annual hospital emergency department visit rate by adults aged 65 years and older with Alzheimer disease was 36.1 visits per 1,000 adults during 2000 to 2020 and increased with age. Ambulance arrival was more frequent for adults with versus without Alzheimer disease (61.0 versus 34.9 percent). More emergency department visits were made by nursing home residents with versus without Alzheimer disease (29.6 versus 5.9 percent). More emergency department visits made by adults with versus without Alzheimer disease resulted in hospital admission (37.2 versus 28.6 percent).
"Among adults age 65 and older, a higher percentage of emergency department visits by adults with Alzheimer disease resulted in hospital admission," the authors write. "However, when examined across age groups, the difference was statistically significant only for visits by those ages 65 to 74."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-10-30 12:00
Read more
- Elevar Therapeutics Resubmits New Drug Application to FDA for Combination of Camrelizumab plus Rivoceranib as First-Line Treatment Option for Unresectable Hepatocellular Carcinoma Boosted by CARES-310 Leading Overall Survival Analysis
- Age-Related Macular Degeneration Tied to Heightened Risk for Rheumatoid Arthritis
- Thryv Therapeutics Granted FDA Orphan Drug Designation for LQT-1213 in Long QT Syndrome Treatment
- U.S. FDA Approves Pfizer’s RSV Vaccine Abrysvo for Adults Aged 18 to 59 at Increased Risk for Disease
- Cilta-Cel Treatment Safe, Effective for Relapsed/Refractory Multiple Myeloma
- Six-Week Abortion Bans: More Than a Third of Women Don't Know They Are Pregnant by 6 Weeks
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions